$NBIX News Banks, hedge funds and what Citi has to tell

New Post Public Reply Private Reply Replies (0) Message Board

Jan 11, 2015 at 11:51 AM

$NBIX News

Banks, hedge funds and what Citi has to tell its rich clients 7:47 a.m. Jan. 13, 2014 - Shawn Langlois
Stock futures gain as S&P 500 looks to halt skid 8:59 a.m. Jan. 7, 2014 - Victor Reklaitis
Yahoo, Palo Alto, Neurocrine are stocks to watch 5:31 a.m. Jan. 7, 2014 - Wallace Witkowski
Palo Alto, Convergys shares rise on acquisitions 5:08 p.m. Jan. 6, 2014 - Wallace Witkowski
Neurocrine Biosciences shares jump 60% on study 4:51 p.m. Jan. 6, 2014 - Wallace Witkowski
Neurocrine Biosciences shares surge on study 4:50 p.m. Jan. 6, 2014 - MarketWatch.com
S&P’s 50-day average remains the technical test 10:10 a.m. July 1, 2013 - Michael Ashbaugh
Volatility spike supports bullish market view 11:07 a.m. June 4, 2013 - Michael Ashbaugh
Volatility spike supports bullish market view 10:59 a.m. June 4, 2013 - Michael Ashbaugh
In focus: Bears trying to gain traction 6:30 p.m. May 29, 2013 - Lawrence G. McMillan
In focus: Awaiting the next move 7:57 p.m. Feb. 6, 2013 - Lawrence G. McMillan
Neurocrine to offer 9.5 mln shares 10:02 a.m. Jan. 19, 2012 - MarketWatch.com
Inspire, Questcor lead drug stocks north 2:55 p.m. April 5, 2011 - Val Brickates Kennedy
Neurocrine climbs on drug update 10:50 a.m. April 5, 2011 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:31 p.m. Feb. 11, 2011 - Kate Gibson
Mannkind sinks in mixed drug sector 3:20 p.m. Feb. 11, 2011 - Val Brickates Kennedy
Drug stocks inch higher; Cytori slides 2:34 p.m. Oct. 8, 2010 - Val Brickates Kennedy
Neurocrine shares jump on analyst rating 9:07 a.m. Oct. 8, 2010 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:26 p.m. Sept. 15, 2010 - MarketWatch
Neurocrine Biosciences shares up 4% 8:33 a.m. June 17, 2010 - Nick Godt

Seeking Alpha's Biotech Weekly: Gilead Rises With Phenex, Bass's Patent Attack, And More 4:00 p.m. Jan. 9, 2015 - Seeking Alpha
Neurocrine Biosciences Starts A Data-Rich Year On The Right Foot 11:37 a.m. Jan. 9, 2015 - Seeking Alpha
AbbVie Stock Down After Guidance, Downgrade 10:49 a.m. Jan. 9, 2015 - Investors Business Daily
Hottest Healthcare Stocks Now – SEM IPXL RDY ZLTQ 6:15 a.m. Jan. 9, 2015 - InvestorPlace.com
6 Serious Biotech and Health Care Movers 9:37 a.m. Jan. 8, 2015 - 247WallSt.com
Neurocrine Bio up on positive Phase 3 results 8:59 a.m. Jan. 8, 2015 - Seeking Alpha
Hottest Healthcare Stocks Now – NBIX IPXL HALO VRX 5:45 a.m. Jan. 8, 2015 - InvestorPlace.com
Hottest Healthcare Stocks Now – HALO NBIX AMAG ENDP 5:45 a.m. Jan. 7, 2015 - InvestorPlace.com
Our 3 Best Performing Stocks Of 2014 6:52 p.m. Jan. 5, 2015 - Seeking Alpha
15 Biotech Names For 2015 2:37 p.m. Jan. 5, 2015 - Seeking Alpha
What Investors Expect From Neurocrine Biosciences' Next Drug Announcement 1:53 p.m. Jan. 2, 2015 - benzinga.com
Biggest Movers in Healthcare Stocks Now – QGEN BABY ISRG REGN 12:45 p.m. Dec. 31, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ISIS NBIX CLDX EXAS 6:15 a.m. Dec. 26, 2014 - InvestorPlace.com
Commit To Buy Neurocrine Biosciences At $17, Earn 30.2% Annualized Using Options 12:18 p.m. Dec. 24, 2014 - TheStreet.com
5 Stocks With Ugly Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 2:15 a.m. Dec. 22, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – NLNK MACK ELGX HZNP 3:00 p.m. Dec. 19, 2014 - InvestorPlace.com
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know 9:20 a.m. Dec. 17, 2014 - TheStreet.com
Auspex Drug Reduces Uncontrolled Movements in Huntington's Patients 4:06 p.m. Dec. 16, 2014 - TheStreet.com
5 Stocks With Poor Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 2:00 a.m. Dec. 15, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – NBIX TECH AZN ISIS 7:30 a.m. Dec. 10, 2014 - InvestorPlace.com

Critical Alerts For Zynga, Neurocrine Biosciences, Yum! Brands, eBay and TrueCar Released By InvestorsObserver 9:31 a.m. Jan. 9, 2015 - PR Newswire - PRF
Neurocrine Biosciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference 1:00 p.m. Jan. 8, 2015 - PR Newswire - PRF
AbbVie Announces Positive Top-Line Results From Phase 3 Study of Investigational Medicine Elagolix in Patients with Endometriosis 8:00 a.m. Jan. 8, 2015 - PR Newswire - PRF
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio 8:50 a.m. Dec. 12, 2014 - PR Newswire - PRF
Just Released: New Research on American Airlines, Staples, Cyren, Neurocrine Biosciences, and Cherokee 9:17 a.m. Dec. 11, 2014 - PR Newswire - PRF
Neurocrine Biosciences Announces Expansion of its Clinical Pipeline 8:00 a.m. Dec. 10, 2014 - PR Newswire - PRF
Neurocrine Biosciences to Present at the 25th Annual Oppenheimer Healthcare Conference 7:00 p.m. Dec. 4, 2014 - PR Newswire - PRF
Neurocrine to Present at the 2014 Deutsche Bank BioFEST and the 26th Annual Piper Jaffray Healthcare Conference 1:00 p.m. Nov. 25, 2014 - PR Newswire - PRF
Retrophin Names Margaret Valeur-Jensen, Ph.D. as General Counsel 8:01 a.m. Nov. 19, 2014 - BusinessWire - BZX
Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference 1:56 p.m. Nov. 12, 2014 - PR Newswire - PRF
Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference 1:00 p.m. Nov. 12, 2014 - PR Newswire - PRF
Neurocrine Biosciences, Inc. Announces Appointment of Darin Lippoldt as Chief Legal Officer 7:30 a.m. Nov. 4, 2014 - PR Newswire - PRF
Neurocrine Biosciences to Present at the Nomura Biotechnology Conference 7:00 p.m. Nov. 3, 2014 - PR Newswire - PRF
Neurocrine Biosciences Reports Third Quarter 2014 Results 4:01 p.m. Nov. 3, 2014 - PR Newswire - PRF
Neurocrine Biosciences Receives Breakthrough Therapy Designation for NBI-98854 in Tardive Dyskinesia 6:30 a.m. Oct. 30, 2014 - PR Newswire - PRF
Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2014 Financial Results 3:05 p.m. Oct. 27, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 7:35 a.m. Oct. 27, 2014 - PR Newswire - PRF
Neurocrine Announces Initiation Of Phase III Study For VMAT2 Inhibitor NBI-98854 3:05 p.m. Oct. 20, 2014 - PR Newswire - PRF
Neurocrine Announces Expansion Of VMAT2 Inhibitor Program With Initiation Of Tourette Syndrome Clinical Study 3:02 p.m. Oct. 2, 2014 - PR Newswire - PRF
Neurocrine Biosciences, Inc. Announces Appointment of Malcolm Lloyd-Smith as Chief Regulatory Officer 4:20 p.m. Oct. 1, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Megan Holdings Investors Face Deadline for Class Action

Forgive my bluntness, but if you've been snoozing on your Megan Holdings Limited (NASDAQ:MGN) shares, it's time to wake up and smell the lawsuit papers. They're flying around faster than news at a market crash. If you snagged those shares between September 26, 2025, and March 25, 2026, or got in during the IPO on September 26, 2025, here's the deal: the deadline looms on...

Ribbonwire Ranch Hits Sheetz Milestone with Campaign

Where Beef Snacks Meet Road Tales Just a year ago, Ribbonwire Ranch, a small Texas-based beef snack producer, made its debut at Sheetz stores. Now, they're not just another brand on the shelf; they're weaving tales from the road with their latest venture, the "Dashboard Diaries" campaign. If you're wondering how a beef snack producer finds itself in an eight-week...

Photronics Investors Must Act by Sept. 4, 2026 Deadline

Action Time for Photronics Investors There's nothing like a looming deadline to get the adrenaline pumping, especially when you're staring down the barrel of a federal securities class action. Photronics, Inc. (NASDAQ: PLAB) has found itself tangled in legal webs, with the clock ticking down to September 4, 2026. That’s the deadline for investors to move on being the...

Innovative Lighting Idea Brightens Indoor Lives

Shedding Light on SUN ORB's Indoor Revolution Sometimes, the best ideas come from simple needs, like wanting a bit of sunshine in your life. That's the deal with this SUN ORB concept—an invention dreamed up by a chap from Oklahoma who's spent too much time away from the natural light outside. We're talking about a wellness-oriented lighting idea that has big ambitions...

LG Electronics Unveils Smart Home Innovations at IFA

Alright, let's dive into this world of shiny new gadgets that LG Electronics has trotted out at the IFA 2026. As European homes get cozier, folks aren't just after any appliance—they're seeking ones that blend smarts, efficiency, and style. So, LG's rolling out seven of their latest and supposedly greatest home appliances, hoping they'll hit the mark with the modern...

Jim Morey Joins Pickleman's to Drive Expansion

Jim Morey: Catalyst for Pickleman's Ambitious Dreams You ever heard of a sandwich joint ready to take on the big leagues? Because that's just what Pickleman's Gourmet Café is banking on with their latest move—tapping none other than Jim Morey for their executive advisory board. And let me tell ya, this ain't some run-of-the-mill hire. We're talking about a guy who's...

Haier and UEFA's Deal: A Game-Changer for Fans?

A Bold Play in the Global Arena There's something big brewing on the horizon, as Haier aligns with the UEFA Champions League. From 2027 to 2031, this move isn't just about slapping a logo on a jersey. Nah, it's more than that. Haier's stepping up its game, aiming to become a real player in weaving technology and sports into the daily lives of millions. "We aim to bring...

Faruqi & Faruqi Urge Wix Investors to Act Now

Ticking Clock for Wix Investors' Legal Moves The buzz in the stock market is louder than a bull on Wall Street, especially if you're tangled up with Wix.com Ltd. (NASDAQ: WIX). We've got Faruqi & Faruqi, LLP laying down serious advice: move fast or maybe lose your spot in line. The deadline to noodle over your position as a lead plaintiff in their federal securities class...

Sunseeker Unveils 2027 LiDAR Models at IFA 2026

Big Moves at IFA 2026 Sunseeker’s latest unveiling at IFA 2026 in Berlin signals a bold leap. They’re stepping beyond the usual automated mowers to unveil a comprehensive, high-tech garden ecosystem for 2027. It’s not just about lawn care anymore; it’s about integrating AI and robotics into our everyday green spaces. This isn’t just tinkering with your garden;...

SimpliTrain's Momentum in LMS Market Heating Up

SimpliTrain Finds its Groove in the LMS Arena Out here in Delray Beach, SimpliTrain's making waves in the Learning Management System (LMS) market, recently snagging the 'Pervasive Player' tag from MarketsandMarkets' 360Quadrants platform. This cloud-based learning powerhouse ain't just playing around; they're doubling down with expansion into AI and other fancy tech bits...